Nom du produit:Fmoc-L-Lys[Oct-(otBu)-Glu-(otBu)-AEEA-AEEA]-OH
IUPAC Name:(2S)-6-[2-(2-{2-[2-(2-{2-[(4S)-5-(tert-butoxy)-4-[18-(tert-butoxy)-18-oxooctadecanamido]-5-oxopentanamido]ethoxy}ethoxy)acetamido]ethoxy}ethoxy)acetamido]-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)hexanoic acid
- CAS:1662688-20-1
- Formule moléculaire:C64H101N5O16
- Pureté:97%
- Numéro de catalogue:CM553755
- Poids moléculaire:1196.53
Pour une utilisation en R&D uniquement..
Détails du produit
- N° CAS:1662688-20-1
- Formule moléculaire:C64H101N5O16
- Point de fusion:-
- Code SMILES:CC(C)(C)OC(=O)CCCCCCCCCCCCCCCCC(=O)N[C@@H](CCC(=O)NCCOCCOCC(=O)NCCOCCOCC(=O)NCCCC[C@@H](C(=O)O)NC(=O)OCC1C2=CC=CC=C2C3=CC=CC=C13)C(=O)OC(C)(C)C
- Densité:
- Numéro de catalogue:CM553755
- Poids moléculaire:1196.53
- Point d'ébullition:
- N° Mdl:
- Stockage:
Category Infos
- Fatty Acid Modified Side Chains
- Fatty acid-modified side chains are small molecule modifiers and are one of the important factors that change the pharmacokinetic behavior of insulin products. Peptide drugs have the problem of short half-life and easy degradation in clinical practice. Introducing fatty acid-modified side chains into peptide drugs can increase the hydrophobicity of the drug and increase the biological half-life, thereby reducing the dosage and frequency of medication.